As of Oct 11
| +1.28 / +7.94%|
The 9 analysts offering 12-month price forecasts for Insmed Inc have a median target of 40.00, with a high estimate of 56.00 and a low estimate of 30.00. The median estimate represents a +129.89% increase from the last price of 17.40.
The current consensus among 9 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.